Clinical Trial Update: Pattern Separation, Brain Derived Neurotrophic Factors, and Mechanisms of Vortioxetine [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on vortioxetine focusing on pattern separation, brain-derived neurotrophic factors, and mechanisms; trial terminated with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depression Unipolar
• Depressive Disorder
• Major Depressive Disorder

Drugs mentioned

• Vortioxetine (vortioxetine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Depressive Disorder, Major Depression | Phase 4 | Status: TERMINATED | Results posted: 2019-10-14